共 21 条
[1]
Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B. Kim KH,Na IH,Cha JM,et al. Taehan Kanho Hakhoe Chi . 2003
[2]
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. Hadziyannis SJ,Tassopoulos NC,Heathcote EJ,et al. The New England Journal of Medicine . 2003
[3]
Thymosin in the treatment of HBeAg-negative chronic hepatitis B. Saruc M,Ozden N,Yuceyar H. Medical Science Monitor . 2003
[4]
Peginterferon alfa-2a alone, lamivudine alone,and the two in combination in patients with HBeAg-negative chronic hepatitis B. Marcellin P,Lau GK,Bonino F,et al. The New England Journal of Medicine . 2004
[5]
Clinical and virological response to adefovir dipovixil for lamivudine -resistant HBeAg -negative hepatitis B. Scotto G,Palumbo E,Fazio V,et al. New Microbiologica . 2005
[6]
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B. Hadziyannis SJ,Tassopoulos NC,Heathcote EJ,et al. The New England Journal of Medicine . 2005
[7]
Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection. Colonno RJ,Genovesi EV,Medina I,et al. The Journal of Infectious Diseases . 2001
[8]
Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy. Lok AS,Hussain M,Cursano C,et al. Hepatology . 2000
[9]
The long term outcome of interferon -alpha treated and untreated patients with HBeAg-negative chronic hepatitis B. Papatheodoridis GV,Manesis E,Hadziyannis SJ. Journal of Hepatology . 2001
[10]
Hepatitis B virus DNA levels, precore mutations,genotypes and histological activity in chronic hepatitis B. Lindh M,Horal P,Dhillon AP,et al. Journal of Viral Hepatitis . 2000